Ioannis Vlachogiannakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
Maquetación 1
Remission of Psoriasis in a Patient with Hepatocellular Carcinoma Treated with Sorafenib | In Vivo
Ioannis Varbobitis - Consultant, Hepatology and Hepatopancreatobiliary Endoscopy - University Hospitals of Leicester NHS Trust | LinkedIn
Modulation of Metabolizing Enzymes by Bisphenol A in Human and Animal Models | Chemical Research in Toxicology
First Diagnosis of Inflammatory Bowel Disease in a 91-Year-Old Man – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Ioannis KOUTSOUNAS | MD PhD | Laiko Hospital, Athens | GASTROENTEROLOGY
Markers of bacterial translocation in end-stage liver disease
First Diagnosis of Inflammatory Bowel Disease in a 91-Year-Old Man
Ioannis KOUTSOUNAS | MD PhD | Laiko Hospital, Athens | GASTROENTEROLOGY
Dose effect plot for the SNB19 cell line treated with 10 doses of DFMO... | Download Scientific Diagram
Current evidence for histone deacetylase inhibitors in pancreatic cancer
Dimitrios KARAGIANNAKIS | Senior Research Associate Fellow | Doctor of Medicine | Academic Department of Gastroenterology
Ioannis KOUTSOUNAS | MD PhD | Laiko Hospital, Athens | GASTROENTEROLOGY
Γαστρεντερολογικό Ιατρείο Ιωάννη Κουτσουνά - Posts | Facebook
Ioannis Stasinos - Consultant Gastroenterologist & Interventional Endoscopist - NIMTS Hospital | LinkedIn
Ioannis Koutsounas Gastroenterologist: Book an online appointment
Association of clinicopathological parameters and HDAC-1, −2, −4 and −6... | Download Table
Ioannis KOUTSOUNAS | MD PhD | Laiko Hospital, Athens | GASTROENTEROLOGY
Ioannis KOUTSOUNAS | MD PhD | Laiko Hospital, Athens | GASTROENTEROLOGY
Histone deacetylase inhibitors and pancreatic cancer: Are there any promising clinical trials?
Ioannis KOUTSOUNAS | MD PhD | Laiko Hospital, Athens | GASTROENTEROLOGY
Ioannis KOUTSOUNAS | MD PhD | Laiko Hospital, Athens | GASTROENTEROLOGY
Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis | Journal of Agricultural and Food Chemistry
